Industry Focus Transcripts

Latin America’s e-commerce giant is flourishing, and it has a huge runway to grow even more, but there are a few huge risks investors should be aware of.

Pandora is changing up its management team, and probably its strategy, following Sirius' $480 million stake in the company, but it may be too late to change the tides.

The Congressional Budget Office announces a discouraging outlook for Trumpcare. Meanwhile, Portola Pharmaceuticals' stock price increases more in one day than it cost last November.

What credit ratings agencies like Moody's and S&P are, what they do, and why you should care about them.

Amidst all the doom and gloom of the retail world, Ulta and TJX are delivering strong results year after year.

What investors need to know about the multitrillion-dollar U.S. shipping industry, and the many extremely varied subsectors within it.

A look under the hood at AbbVie Inc., how Novartis is prepping to fight Regeneron, and can Clovis capture the lead in the PARP race?

More and more people are shorting tech giants like Apple and Tesla, but the numbers aren't necessarily cause for concern.

Our finance experts tell high school and college grads some of the most important things they need to know about personal finance before they go out into the working world.

The grocery industry is bracing itself for further disruption as e-commerce giant Amazon announced a surprise buyout of Whole Foods Market. Meanwhile, the Nordstrom family is weighing their options for taking the department store private.

GE’s CEO just retired, but he left the company perfectly positioned for a green energy-fueled future.

The House of Representatives voted last week in favor of the Financial CHOICE Act, which is designed to roll back the enhanced regulatory regime laid out in the Dodd-Frank Act of 2010.

Biosimilars could be the next big thing in biotech, and thanks to a recent Supreme Court decision, biosimilar drug developers could reap billions of dollars more over time.

And the biggest winner will be U.S. consumers.

Railways might sound like a boring industry, but the returns in the last five years are dazzling, and show no sign of slowing down.

After presentations at the annual American Society of Clinical Oncology conference this week sent shares higher, investors in bluebird bio, TG Therapeutics, and Loxo Oncology are cheering.

Video game publishers have gone on an incredible run so far in 2017. What's sparked the rally and can it continue?

Citizens Financial became the biggest bank stock IPO in history when it went public in 2014. Since then, it's orchestrated an impressive turnaround.

In its last private funding round, Blue Apron reached a valuation of over $2 billion. Now, the company has its sights set on the public market. I dig into the IPO filing to break down the financials and business model for investors.

Last week we showered Activision, Take-Two, and EA with love, but what about pure-play mobile game publishers like Zynga and Glu Mobile? Do they deserve a spot on your watch list?